Cliff Cho

Preoperative Glycosylated Hemoglobin A1C Impacts Long‐Term Outcomes Following Curative‐Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors

Surgical outcomes of gastro‐entero‐pancreatic neuroendocrine tumors G3 versus neuroendocrine carcinoma

Recurrence of Non‐functional Pancreatic Neuroendocrine Tumors After Curative Resection: A Tumor Burden‐Based Prediction Model

Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors

Clinical relevance of performing endoscopic ultrasound‐guided fine‐needle biopsy for pancreatic neuroendocrine tumors less than 2 cm

Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi‐institutional study of 392 cases

New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors

Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group

Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined

Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis

Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence

Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection

Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group

Nomogram predicting the risk of recurrence after curative‐intent resection of primary non‐metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group